In a recent study, the team of Vassilis Roukos developed a new method that simultaneously assesses the location and structure of DNA double-strand breaks made by the genome-editing tool CRISPR/Cas9.
This methodology, which they named BreakTag, allows scientists to design and test better CRISPR tools that can be used in personalised genome editing to treat currently incurable genetic diseases.
